SCHEMBL25218482

SCHEMBL25218482

CCOC(=O)c1ccc2[nH]c3ccc(Cc4cccc(F)c4)cc3c2c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.62
ALDH1A1 P00352 6/20 0.62
MAPT P10636 4/20 0.62
MEN1 O00255 3/20 0.62
KMT2A Q03164 3/20 0.62
HCRTR1 O43613 2/20 0.62
RAB9A P51151 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
HSD17B10 Q99714 5/20 0.52
MAPK1 P28482 3/20 0.52
HPGD P15428 3/20 0.52
POLB P06746 2/20 0.52
NPC1 O15118 1/20 0.51
ALOX5 P09917 2/20 0.50
PTGES O14684 1/20 0.50
TUBB4A P04350 1/20 0.49
TUBB P07437 1/20 0.49
TUBA3C P0DPH7 1/20 0.49
TUBA1B P68363 1/20 0.49
TUBA4A P68366 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30413676 1.00 KDM4E (0.62) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL7979591 0.84 KDM4E (0.72) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL68639 0.81 KDM4E (0.85) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL4726935 0.78 KDM4E (1.00) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL4728034 0.76 KDM4E (0.76) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL70604 0.76 ALDH1A1 (0.81) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL25203911 0.76 SNCA (0.42) KDM4EMAPTHPGDALOX5PTGES
SCHEMBL30413527 0.76 SNCA (0.42) KDM4EMAPTHPGDALOX5PTGES
SCHEMBL22552106 0.76 TUBB4A (0.78) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL29902897 0.76 TUBB4A (0.78) KDM4EALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230278958-A1 TRICYCLIC HETEROCYCLES MERCK PATENT GMBH (DE) 2023-09-07 US disclosed
US-20230278958-A1 TRICYCLIC HETEROCYCLES MERCK PATENT GMBH (DE) 2023-09-07 US disclosed
US-20230278958-A1 TRICYCLIC HETEROCYCLES MERCK PATENT GMBH (DE) 2023-09-07 US disclosed
EP-4185564-A1 TRICYCLIC HETEROCYCLES Merck Patent GmbH (DE) 2023-05-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278958-A1 TRICYCLIC HETEROCYCLES YAP1, TERF2IP, TEAD1 KDM4E 2608/4885ALDH1A1 3813/4885MAPT 2472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.